Cannabis

Overview

Tannenbaum Helpern offers high quality, highly tailored services required by its clients involved in the emerging, closely regulated medical and adult-use (or recreational-use) cannabis industry. Our cannabis-related clients span the cannabis ecosystem and include multi-state operators, marijuana tech companies, CBD companies, U.S. and non-U.S. cannabis-focused private investment funds, and institutional investors with interests in cannabis companies in the U.S. and Canada. For these clients, the Firm provides a wide range of legal services including general corporate, venture capital, private equity, mergers & acquisitions, investment management, intellectual property, business reorganizations and creditors’ rights, general and specialized taxation, employment, litigation, cybersecurity and data privacy, in addition to advice relating to compliance with United States state laws and regulations governing cannabis. We also advise our clients on the inconsistencies between many state laws and federal law governing cannabis.

*The distribution and sale of marijuana, as well as its use and possession, remain criminalized under federal law. We do not intend any of our legal advice to provide assistance in the violation of federal law.

Representative Experience

• Provided corporate, private equity and mergers and acquisitions structuring advice to a series of private funds in connection with their acquisition of a $60 million controlling interest in a publicly-traded Canadian medical marijuana company in a club deal with high profile Canadian partners.
• Provided investment advisory, regulatory and tax advice to a U.S. feeder fund into a Canadian cannabis-focused private investment fund.
• Provided investment advisory and regulatory advice to an investment advisor to private funds in connection with their investments in the cannabis industry.
• Provided corporate, regulatory and governance advice to a major investor in a U.S. state-licensed medical marijuana grower and retailer.
• Provided corporate and venture capital advice to an institutional investor in connection with its evaluation and negotiation of an investment in a state-licensed vertically integrated cannabis company.